Gongwin Biopharm Holdings Company

Gongwin Biopharm Holdings Company Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 27
Employees
  • Stock Symbol
  • 6617
Stock Symbol
  • Share Price
  • $2.02
  • (As of Wednesday Closing)

Gongwin Biopharm Holdings Company General Information

Description

Gongwin Biopharm Holdings Co Ltd is a Taiwanese biotech and pharmaceutical company engaged in research and development of anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
ROCO
Primary Office
  • 3rd Floor, No. 80, Jianguo North Road
  • Zhongshan District
  • Taipei City, 104-91
  • Taiwan
+886 02 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gongwin Biopharm Holdings Company Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.02 $1.99 $1.70 - $2.94 $208M 103M 45.9K -$0.03

Gongwin Biopharm Holdings Company Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 256,356 256,356 202,374 193,620
Revenue 8 8 2 35
EBITDA (3,296) (3,296) (3,459) (4,059)
Net Income (3,554) (3,554) (3,671) (4,061)
Total Assets 25,867 25,867 30,526 22,028
Total Debt 787 787 3,226 1,258
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ready to get started?

Request a free trial